GlaxoSmithKline (GSK) Pharma and Biotech Sector

  • Latest quote

    1,485.80p (mid)

  • Current Change (%)

    -0.72%

  • Price

    Bid: 1,486.00p

    Offer: 1,486.20p

  • Today

    High: 1,496.20p

    Low: 1,478.40p

  • This year

    High: 1,619.40p

    Low: 1,242.80p

  • Information

    Volume: 4,657,334

    Market Cap: £73715.52M


GlaxoSmithKline Overview

UK-based GlaxoSmithKline is one of the world's leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.

GlaxoSmithKline RNS Feed

Title Release date
ViiV submits HIV 2DR regulatory application to EMA 09:00 - September 14, 2018
Director/PDMR Shareholding 17:43 - September 12, 2018
New analysis on efficacy of anti-IL5 biologics SEA 08:00 - September 10, 2018
GSK receives CRL from FDA for mepolizumab in COPD 07:00 - September 10, 2018
Director/PDMR Shareholding 14:24 - September 7, 2018
Director/PDMR Shareholding 14:18 - September 7, 2018
Total Voting Rights 17:00 - September 3, 2018
GSK publishes Q4 2018 Dividend Dates 17:12 - August 30, 2018
EU approve Nucala in severe asthma in children 08:12 - August 30, 2018
Director/PDMR Shareholding 10:16 - August 24, 2018
Positive headline results for ViiV HC ATLAS study 07:00 - August 15, 2018
Director/PDMR Shareholding 15:00 - August 10, 2018
Director/PDMR Shareholding 12:35 - August 8, 2018
Iain Mackay appointed GSK Chief Financial Officer 07:00 - August 7, 2018
Publication of Base Prospectus 17:07 - August 2, 2018

NOTE: This is based on 199 open tips for this company


Total Number of Share tips :

396

View all GlaxoSmithKline Tips



Daily share tips delivered straight to your pc, tablet & mobile

Join Free Today